association

Full identifier: http://purl.org/np/RAZAt4kxVlbMHpagMX_Qsu-XR8Gsq_RTvkmcpfF4ECURo#association

Assigned to 1 class:

Minted in Nanopublication

 RAZAt4kxVl comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAZAt4kxVl... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-13T15:29:51.272+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAZAt4kxVl... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAZAt4kxVl... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAZAt4kxVl... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-13T13:29:51.272Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
sulfasalazine delayed release tablets are indicated a b c d 1 sulfasalazine delayed release tablets are particularly indicated in patients with ulcerative colitis who cannot take uncoated sulfasalazine tablets because of gastrointestinal intolerance and in whom there is evidence that this intolerance is not primarily the result of high blood levels of sulfapyridine and its metabolites e g patients experiencing nausea and vomiting with the first few doses of the drug or patients in whom a reduction in dosage does not alleviate the adverse gastrointestinal effects in patients with rheumatoid arthritis or juvenile rheumatoid arthritis rest and physiotherapy as indicated should be continued unlike anti inflammatory drugs sulfasalazine delayed release tablets do not produce an immediate response concurrent treatment with analgesics and or nonsteroidal anti inflammatory drugs is recommended at least until the effect of sulfasalazine delayed release tablets is apparent
Leoni Bücken
2021-06-13T13:29:51.272Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-13T13:29:51.272Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-13T13:29:51.272Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-13T13:29:51.272Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-13T13:29:51.272Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-13T13:29:51.272Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-13T13:29:51.272Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)